Get the Stockscreener App
22.93
5.17%
-1.25
After Hours:
23.00
0.07
+0.31%
Novocure Ltd Stock (NVCR) Latest News
What was NovoCure Ltd (NVCR)’s performance in the last session? - US Post News
Evercore ISI Upgrades NovoCure Ltd (NVCR) to an Outperform from an In-line - Knox Daily
Financial Snapshot: Analyzing Spectral AI Inc (MDAI)’s Key Ratio Metrics - The Dwinnex
Ratio Examination: NovoCure Ltd (NVCR)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Exchange Traded Concepts LLC Has $859,000 Stock Holdings in NovoCure Limited (NASDAQ:NVCR) - MarketBeat
NovoCure Ltd (NVCR) Should Be Considered Now, Despite A Loss Of -28.16% From High - Stocks Register
Nisa Investment Advisors LLC Grows Position in NovoCure Limited (NASDAQ:NVCR) - Defense World
Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business' - Benzinga
Brokerages Set NovoCure Limited (NASDAQ:NVCR) PT at $32.67 - MarketBeat
NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
NovoCure Ltd (NASDAQ: NVCR): Overvalued In Comparison To Others? - Stocks Register
NovoCure (NASDAQ:NVCR) Stock Price Crosses Above 50-Day Moving AverageWhat's Next? - MarketBeat
Novocure Ltd. to Host Earnings Call - ACCESS Newswire
Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland - Yahoo Finance
Investing in NovoCure (NASDAQ:NVCR) a year ago would have delivered you a 85% gain - Yahoo Finance
Novocure gets approval for rooftop penthouse at downtown Portsmouth headquarters - AOL
FY2024 EPS Estimates for NovoCure Lifted by HC Wainwright - Defense World
HC Wainwright Increases Earnings Estimates for NovoCure - MarketBeat
NovoCure’s (NVCR) Buy Rating Reiterated at HC Wainwright - Defense World
HC Wainwright Forecasts NovoCure FY2029 Earnings - Defense World
Wedbush Has Positive Outlook of NovoCure FY2024 Earnings - Defense World
HC Wainwright Predicts NovoCure FY2029 Earnings - MarketBeat
Wedbush Comments on NovoCure's FY2024 Earnings (NASDAQ:NVCR) - MarketBeat
Novocure's COO Mukund Paravasthu sells $57,906 in shares By Investing.com - Investing.com South Africa
Novocure's COO Mukund Paravasthu sells $57,906 in shares - Investing.com India
NovoCure Ltd (NVCR) Shares Down 3.67% on Jan 14 - GuruFocus.com
NovoCure (NASDAQ:NVCR) Given Buy Rating at HC Wainwright - MarketBeat
Deep Dive Into NovoCure Stock: Analyst Perspectives (7 Ratings) - Benzinga
NovoCure’s (NVCR) Neutral Rating Reaffirmed at Wedbush - Defense World
NovoCure's (NVCR) Neutral Rating Reiterated at Wedbush - MarketBeat
Is Now The Time To Buy NovoCure Ltd (NASDAQ: NVCR) Stock? - Stocks Register
Novocure reports revenue growth, FDA approvals in 2024 - Investing.com India
Novocure Reports Strong 19% Revenue Growth, Hits $605M as Cancer Treatment Platform Expands - StockTitan
Investing in NovoCure (NASDAQ:NVCR) a year ago would have delivered you a 97% gain - Simply Wall St
NovoCure Limited (NASDAQ:NVCR) Shares Acquired by Versant Capital Management Inc - Defense World
NovoCure Limited (NASDAQ:NVCR) Receives $32.67 Average PT from Brokerages - MarketBeat
NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Novocure CEO to Present at J.P. Morgan Healthcare Conference, Announces Investor Meetings - StockTitan
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
NovoCure Limited (NASDAQ:NVCR) Shares Acquired by Franklin Resources Inc. - MarketBeat
Geode Capital Management LLC Acquires 29,871 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure (NASDAQ:NVCR) Reaches New 12-Month HighShould You Buy? - MarketBeat
Research Analysts’ Recent Ratings Updates for NovoCure (NVCR) - Defense World
Novocure's SWOT analysis: oncology med-tech firm's stock faces growth challenges - Investing.com Australia
Tumor Treating Fields Market Growth in Future Scope 2024-2031 | Novocure GmbH and Zai Lab - openPR
Novocure's SWOT analysis: oncology med-tech firm's stock faces growth challenges By Investing.com - Investing.com South Africa
NovoCure (NASDAQ:NVCR) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World
Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio? - Benzinga
Novocure Stock Hits 52-Week High at $32.65 Amidst Strong Yearly Growth - Investing.com Australia
NovoCure (NASDAQ:NVCR) Shares Gap Up on Analyst Upgrade - MarketBeat
Novocure price target raised to $42 from $28 at Piper Sandler - Yahoo Finance
Novocure Stock Hits 52-Week High at $32.65 Amidst Strong Yearly Growth By Investing.com - Investing.com South Africa
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):